|
Since 1996 ElectroChemiLuminescence (ECL) technology has been Roche’s immunochemistry detection technology of choice. It was first used in the clinical laboratory on the Elecsys® 2010 analyzer with 6 immunoassay applications. Today ECL is the most successful chemiluminescence technology with more than 75 applications and 20,000 instrument placements worldwide. No other IVD company can offer an automated detection technology that matches ECL’s unique blend of controlled reaction, precision and sensitivity, low sample volume, wide measuring range, and rapid measurement.
Click
here to see how ECL detection technology works.  |